These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 36662772)

  • 21. Facial volume augmentation in 2014: overview of different filler options.
    Luebberding S; Alexiades-Armenakas M
    J Drugs Dermatol; 2013 Dec; 12(12):1339-44. PubMed ID: 24301234
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hand recontouring with calcium hydroxylapatite (Radiesse).
    Edelson KL
    J Cosmet Dermatol; 2009 Mar; 8(1):44-51. PubMed ID: 19250166
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Optimal Changes Seen in Patients After Treatment With Poly- l -Lactic Acid: A Retrospective Descriptive Study.
    Alcotzer I; Liassidou A; Hexsel D; Tsur Shenhav L; Artzi O
    Dermatol Surg; 2024 Jan; 50(1):69-74. PubMed ID: 37910604
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diluted Calcium Hydroxylapatite for Skin Tightening of the Upper Arms and Abdomen.
    Lapatina NG; Pavlenko T
    J Drugs Dermatol; 2017 Sep; 16(9):900-906. PubMed ID: 28915285
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Calcium hydroxylapatite microspheres activate fibroblasts through direct contact to stimulate neocollagenesis.
    Nowag B; Casabona G; Kippenberger S; Zöller N; Hengl T
    J Cosmet Dermatol; 2023 Feb; 22(2):426-432. PubMed ID: 36575882
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New and emerging concepts in soft tissue fillers: roundtable discussion.
    Sundaram H; Flynn T; Cassuto D; Lorenc ZP
    J Drugs Dermatol; 2012 Aug; 11(8):s12-24; discussion s25. PubMed ID: 22859224
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dermal fillers and combinations of fillers for facial rejuvenation.
    Beer K
    Dermatol Clin; 2009 Oct; 27(4):427-32, v. PubMed ID: 19850192
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Facial volumetric correction with injectable poly-L-lactic acid.
    Vleggaar D
    Dermatol Surg; 2005 Nov; 31(11 Pt 2):1511-7; discussion 1517-8. PubMed ID: 16416633
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety in immediate reconstitution of poly-l-lactic acid for facial biostimulation treatment.
    Bravo BSF; Carvalho RM
    J Cosmet Dermatol; 2021 May; 20(5):1435-1438. PubMed ID: 32633843
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Radiographic and computed tomographic studies of calcium hydroxylapatite for treatment of HIV-associated facial lipoatrophy and correction of nasolabial folds.
    Carruthers A; Liebeskind M; Carruthers J; Forster BB
    Dermatol Surg; 2008 Jun; 34 Suppl 1():S78-84. PubMed ID: 18547186
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improved Neocollagenesis and Skin Mechanical Properties After Injection of Diluted Calcium Hydroxylapatite in the Neck and Décolletage:A Pilot Study.
    Yutskovskaya YA; Kogan EA
    J Drugs Dermatol; 2017 Jan; 16(1):68-74. PubMed ID: 28095536
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Investigator global evaluations of efficacy of injectable poly-L-lactic acid versus human collagen in the correction of nasolabial fold wrinkles.
    Brandt FS; Cazzaniga A; Baumann L; Fagien S; Glazer S; Kenkel JM; Lowe NJ; Monheit GD; Narins RS; Rendon MI; Rohrich RJ; Werschler WP
    Aesthet Surg J; 2011 Jul; 31(5):521-8. PubMed ID: 21719865
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Novel, Optimized Method to Accelerate the Preparation of Injectable Poly-L-Lactic Acid by Sonication.
    Li CN; Wang CC; Huang CC; Wang HH; Hsu NJ
    J Drugs Dermatol; 2018 Aug; 17(8):894-898. PubMed ID: 30124730
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A decade of experience with injectable poly-L-lactic acid: a focus on safety.
    Bartus C; William Hanke C; Daro-Kaftan E
    Dermatol Surg; 2013 May; 39(5):698-705. PubMed ID: 23379657
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The history behind the use of injectable poly-L-lactic acid for facial and nonfacial volumization: the positive impact of evolving methodology.
    Vleggaar D; Fitzgerald R; Lorenc ZP
    J Drugs Dermatol; 2014 Apr; 13(4 Suppl):s32-4. PubMed ID: 24719075
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Physiochemical Characteristics of Calcium Hydroxylapatite (CaHA).
    Lorenc ZP; Bass LM; Fitzgerald R; Goldberg DJ; Graivier MH
    Aesthet Surg J; 2018 Apr; 38(suppl_1):S8-S12. PubMed ID: 29897516
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Physiochemical Characteristics of Poly-L-Lactic Acid (PLLA).
    Fitzgerald R; Bass LM; Goldberg DJ; Graivier MH; Lorenc ZP
    Aesthet Surg J; 2018 Apr; 38(suppl_1):S13-S17. PubMed ID: 29897517
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of polycaprolactone and calcium hydroxylapatite dermal fillers in a rat model.
    Yanatma I; Sarac G; Gul M; Gul S; Kapicioglu Y
    Dermatol Ther; 2021 Jan; 34(1):e14716. PubMed ID: 33368862
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Complete biodegradable nature of calcium hydroxylapatite after injection for malar enhancement: an MRI study.
    Pavicic T
    Clin Cosmet Investig Dermatol; 2015; 8():19-25. PubMed ID: 25709485
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A multicenter, randomized trial comparing calcium hydroxylapatite to two hyaluronic acids for treatment of nasolabial folds.
    Moers-Carpi M; Vogt S; Santos BM; Planas J; Vallve SR; Howell DJ
    Dermatol Surg; 2007 Dec; 33 Suppl 2():S144-51. PubMed ID: 18086052
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.